Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma by Amanda A. van Vliet, Anna-Maria Georgoudaki, Monica Raimo, Tanja D. de Gruijl, Jan Spanholtz

Get full text

384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signatures by Jan Spanholtz, Monica Raimo, Daniëlle Steenmans, Amanda van Vliet, Anna-Maria Georgoudaki, Adil Duru, Denise Vodegel

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D by Ece Canan Sayitoglu, Ece Canan Sayitoglu, Anna-Maria Georgoudaki, Anna-Maria Georgoudaki, Anna-Maria Georgoudaki, Michael Chrobok, Didem Ozkazanc, Benjamin J. Josey, Benjamin J. Josey, Muhammad Arif, Kim Kusser, Michelle Hartman, Tamara M. Chinn, Renee Potens, Cevriye Pamukcu, Robin Krueger, Cheng Zhang, Adil Mardinoglu, Adil Mardinoglu, Evren Alici, Harry Thomas Temple, Tolga Sutlu, Adil Doganay Duru, Adil Doganay Duru, Adil Doganay Duru

Get full text

330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16 by Jan Spanholtz, Monica Raimo, Nina Lamers-Kok, Didem Özkazanc, Daniëlle Steenmans, Amanda van Vliet, Anna-Maria Georgoudaki, Adil Duru, Denise Vodegel

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies by Nina Lamers-Kok, Denise Panella, Anna-Maria Georgoudaki, Haiping Liu, Didem Özkazanc, Lucia Kučerová, Adil Doganay Duru, Jan Spanholtz, Monica Raimo

Get full text

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells by Amanda A. van Vliet, Ella Peters, Denise Vodegel, Daniëlle Steenmans, Monica Raimo, Susan Gibbs, Tanja D. de Gruijl, Adil D. Duru, Jan Spanholtz, Anna-Maria Georgoudaki

Get full text

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis by Anna-Maria Georgoudaki, Kajsa E. Prokopec, Vanessa F. Boura, Eva Hellqvist, Silke Sohn, Jeanette Östling, Rony Dahan, Robert A. Harris, Mattias Rantalainen, Daniel Klevebring, Malin Sund, Suzanne Egyhazi Brage, Jonas Fuxe, Charlotte Rolny, Fubin Li, Jeffrey V. Ravetch, Mikael C.I. Karlsson

Get full text

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma by Nadia Mensali, Hakan Köksal, Sandy Joaquina, Patrik Wernhoff, Nicholas P. Casey, Paola Romecin, Carla Panisello, René Rodriguez, Lene Vimeux, Asta Juzeniene, Marit R. Myhre, Anne Fåne, Carolina Castilla Ramírez, Solrun Melkorka Maggadottir, Adil Doganay Duru, Anna-Maria Georgoudaki, Iwona Grad, Andrés Daniel Maturana, Gustav Gaudernack, Gunnar Kvalheim, Angel M. Carcaboso, Enrique de Alava, Emmanuel Donnadieu, Øyvind S. Bruland, Pablo Menendez, Else Marit Inderberg, Sébastien Wälchli

Get full text